Skip to main content
OpenTrials
Completed

NCT Number: NCT02100137

Women With Asymptomatic Endometrial Hyperplasia

The purpose of this study is to evaluate the clinical meaning of an endometrial hyperplasia diagnosed using a vaginal ultrasound during routine gynecological examination.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • asymptomatic women with endometrial hyperplasia diagnosed using a vaginal ultrasound

Exclusion criteria

  • postmenopausal bleeding

Treatment and study plan

vaginal ultrasound

Other

vaginal ultrasound performed at a routine gyn examination

Primary outcomes

  1. Number of invasive endometrial cancers

    Time frame: Participants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days

Secondary outcomes

  1. Number of women with atypical endometrial hyperplasia

    Time frame: Participants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Acronym: FAME-ENDO

Important dates

Study start
2006
Primary completion
2010
Study completion
2012
First posted
Mar 31, 2014
Registry last updated
Mar 31, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.